NCT01210339View on ClinicalTrials.gov

An Interaction Study to Evaluate the Effect of Esomeprazole/Acetylsalicylic Acid on the Metabolism and Effect of Clopidogrel

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Healthy Volunteers
Interventions
DRUG

Clopidogrel

Clopidogrel

DRUG

Esomeprazole/ASA

20 mg/81 mg once daily for five days (Day 5-9)

Trial Locations (1)

Unknown

Research Site, Uppsala

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY